ArticleApplied microbiology and biotechnology2025
Enhancing conjugation from E. coli to Streptomyces coelicolor by incorporating traJ into mobilizable plasmids.
Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineering an IndustrialMicroorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Streptomyces species are prolific producers of bioactive natural products, yet their genetic manipulation remains constrained by inefficient DNA delivery methods in many strains. Conjugation from methylation-deficient Escherichia coli has become the preferred approach for introducing plasmids into Streptomyces, relying on the presence of the oriT sequence within the mobilizable plasmid and the conjugation machinery (tra genes) encoded on the non-mobilizable helper plasmid pUZ8002. Among these, traJ encodes an essential component of the relaxosome. An additional copy of traJ is present downstream of oriT in some mobilizable plasmids, whereas many other commonly used plasmids lack traJ. Here, we investigated the impact of including traJ in mobilizable plasmids on conjugation efficiency by engineering two oriT-containing plasmids that initially lacked traJ: the ΦC31 integrative vector pRASK-SP44 and the non-replicative transposon delivery vector pHL734. We also examined the effect of introducing a second copy of traJ into the recombination-based chromosomal end-removal vector pCER. Incorporation of traJ into pRASK-SP44 and pHL734 resulted in tenfold and 100-fold increases in transconjugant numbers, respectively. Furthermore, introducing a second copy of traJ into pCER led to a fivefold improvement in plasmid transfer. Our data suggest that the inclusion of traJ improves transfer efficiency and may help overcome limiting steps in conjugation from E. coli to Streptomyces. Modulating the presence and copy number of traJ could represent a simple yet effective strategy to enhance genetic accessibility in Streptomyces. These findings have broad implications for the optimisation of genetic tools used in Streptomyces genome engineering and natural product discovery. KEY POINTS: • traj in mobilizable plasmids enhances conjugation to S. coelicolor. • traj increases plasmid transfer efficiency up to 100-fold in S. coelicolor. • traj may aid development of genetic tools for genome engineering in Streptomyces.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.